2020年10月 – ページ 2
FDA approved Gilead Sciences' remdesivir as the first fully approved treatment for COVID-19, despite WHO findings of minimal impact on mortality. Gilead faced criticism for high pricing and profit motives. Japan also approved remdesivir, highlighting global efforts to combat the pandemic with antiviral treatments.
Reference News
2020年10月 – ページ 2
FDA approved Gilead Sciences' remdesivir as the first fully approved treatment for COVID-19, despite WHO findings of minimal impact on mortality. Gilead faced criticism for high pricing and profit motives. Japan also approved remdesivir, highlighting global efforts to combat the pandemic with antiviral treatments.